These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 34237031)

  • 1. NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake.
    Lee YA; Lee H; Im SW; Song YS; Oh DY; Kang HJ; Won JK; Jung KC; Kwon D; Chung EJ; Hah JH; Paeng JC; Kim JH; Choi J; Kim OH; Oh JM; Ahn BC; Wirth LJ; Shin CH; Kim JI; Park YJ
    J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34237031
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Pekova B; Sykorova V; Dvorakova S; Vaclavikova E; Moravcova J; Katra R; Astl J; Vlcek P; Kodetova D; Vcelak J; Bendlova B
    Thyroid; 2020 Dec; 30(12):1771-1780. PubMed ID: 32495721
    [No Abstract]   [Full Text] [Related]  

  • 3. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
    Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Groussin L; Bessiene L; Arrondeau J; Garinet S; Cochand-Priollet B; Lupo A; Zerbit J; Clerc J; Huillard O
    Thyroid; 2021 Oct; 31(10):1603-1604. PubMed ID: 34405703
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers.
    Syed AR; Gorana A; Nohr E; Yuan XK; Amin MASc P; Ghaznavi S; Lamb D; McIntyre J; Eszlinger M; Paschke R
    Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38642578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application value of multi-gene mutation detection in the clinical management of pediatric papillary thyroid carcinoma: a preliminary exploration.
    Wang Y; Wang H; Tan G; Wu X; Wang B; Tan Z; Du J; Li X; Xu Y; Yan N; Qian X
    Front Endocrinol (Lausanne); 2024; 15():1405142. PubMed ID: 38904052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rearranged-in-transfection inhibitors: emerging agnostic targeted therapies for solid tumors.
    Saleh K; Felefly T; Khalife N; Kourie HR
    Pharmacogenomics; 2021 Apr; 22(5):247-250. PubMed ID: 33754802
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of RET rearrangements in papillary thyroid carcinoma using RT-PCR and FISH techniques - A molecular and clinical analysis.
    Musholt TJ; Staubitz JI; Antonio Cámara RJ; Musholt PB; Humberg D; Springer E; Schad A
    Eur J Surg Oncol; 2019 Jun; 45(6):1018-1024. PubMed ID: 30472213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion Oncogenes Are the Main Genetic Events Found in Sporadic Papillary Thyroid Carcinomas from Children.
    Cordioli MI; Moraes L; Bastos AU; Besson P; Alves MT; Delcelo R; Monte O; Longui C; Cury AN; Cerutti JM
    Thyroid; 2017 Feb; 27(2):182-188. PubMed ID: 27849443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
    Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
    Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and Cytogenetic Features of NTRK Fusions Enriched in BRAF and RET Double-Negative Papillary Thyroid Cancer.
    Wu S; Liu Y; Li K; Liang Z; Zeng X
    J Mol Diagn; 2023 Aug; 25(8):569-582. PubMed ID: 37236546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodal Metastases Associated With Fusion Oncogenes Are Age Dependent in Young Adult Patients With Thyroid Cancer.
    Li H; Han R; Meng L; Sun Y; Zhao M; Zhou W; Xie J; Yu D; Shen L; Zhou Y; Wang S; Yan J; Wang W; Ye L
    J Clin Endocrinol Metab; 2023 Dec; 109(1):143-150. PubMed ID: 37536280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive droplet digital PCR for detection of RET fusion in papillary thyroid cancer.
    Chen M; Xue J; Sang Y; Jiang W; He W; Hong S; Lv W; Xiao H; Liu R
    BMC Cancer; 2023 Apr; 23(1):363. PubMed ID: 37081420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained Response with Dose-reduced Selpercatinib in a Pediatric Patient with Metastatic NCOA4-RET Fusion Papillary Thyroid Carcinoma.
    Suydam AC; Bach A; Markovina S; Grigsby P; Sprague J; Armstrong AE
    J Pediatr Hematol Oncol; 2023 Nov; 45(8):e984-e987. PubMed ID: 37565829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population.
    Brzeziańska E; Karbownik M; Migdalska-Sek M; Pastuszak-Lewandoska D; Włoch J; Lewiński A
    Mutat Res; 2006 Jul; 599(1-2):26-35. PubMed ID: 16483615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive
    Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
    Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima.
    Iyama K; Matsuse M; Mitsutake N; Rogounovitch T; Saenko V; Suzuki K; Ashizawa M; Ookouchi C; Suzuki S; Mizunuma H; Fukushima T; Suzuki S; Yamashita S
    Thyroid; 2017 Jun; 27(6):811-818. PubMed ID: 28351223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical aspect of NTRK-fusions in pediatric papillary thyroid cancer.
    Ricarte-Filho JC; Halada S; O'Neill A; Casado-Medrano V; Laetsch TW; Franco AT; Bauer AJ
    Cancer Genet; 2022 Apr; 262-263():57-63. PubMed ID: 35092884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug approval: Selpercatinib and pralsetinib - RET-altered thyroid cancer].
    Courtier B; Hadoux J
    Bull Cancer; 2021 Nov; 108(11):989-991. PubMed ID: 34598787
    [No Abstract]   [Full Text] [Related]  

  • 20. Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary Thyroid Carcinoma.
    Stosic A; Fuligni F; Anderson ND; Davidson S; de Borja R; Acker M; Forte V; Campisi P; Propst EJ; Wolter NE; Chami R; Mete O; Malkin D; Shlien A; Wasserman JD
    Cancer Res; 2021 Nov; 81(22):5625-5637. PubMed ID: 34535459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.